Interaction of Drugs and Chinese Herbs: Pharmacokinetic Changes of Tolbutamide and Diazepam Caused by Extract of Angelica dahurica
- 1 August 2000
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 52 (8) , 1023-1029
- https://doi.org/10.1211/0022357001774750
Abstract
The inhibitory effects of Angelica dahurica root extract on rat liver microsomal cytochrome P450 and drug-drug interactions were studied. The 2α- and 16α-hydroxylase activity of testosterone were most strongly inhibited, with 17.2% and 28.5% of their activity remaining, respectively, after oral administration of A. dahurica extract at a 1 g kg−1 dose. 6β-Hydroxylase activity was also inhibited, with 70% of its activity remaining, under the same conditions. In addition, treatment with the extract inhibited the metabolism of tolbutamide, nifedipine and bufuralol. These results showed that the extract inhibited the various isoforms of cytochrome P450 such as CYP2C, CYP3A and CYP2D1. The A. dahurica extract delayed elimination of tolbutamide after intravenous administration at a 10 mg kg−1 dose to rats. Thus, the extract altered the liver intrinsic clearance. It had little effect, however, on the pharmacokinetic parameters of diazepam after intravenous administration at 10 mg kg−1. Since diazepam showed high clearance, it underwent hepatic blood flow rate-limited metabolism. Therefore, the change of intrinsic clearance had little effect on hepatic clearance. However, the Cmax value after oral administration of diazepam with extract treatment was four times that with non-treatment. It was suggested that the first-pass effect was changed markedly by the extract. High-dose (1 g kg−1), but not low dose (0.3 g kg−1), administration of A. dahurica extract increased significantly the duration of rotarod disruption following intravenous administration of diazepam at 5 mg kg−1. It was concluded that administration of A. dahurica extract has the potential to interfere with the metabolism, by liver cytochrome P450, of other drugs.Keywords
This publication has 20 references indexed in Scilit:
- Specific CYP3 A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interactionPharmacogenetics, 1997
- Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.Journal of Clinical Investigation, 1997
- Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy menEuropean Journal of Clinical Pharmacology, 1997
- Interaction between grapefruit juice and midazolam in humans*Clinical Pharmacology & Therapeutics, 1995
- Effects of Byakushi and Ogon on the hepatic drug metabolizing enzymes in rats.Folia Pharmacologica Japonica, 1994
- Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomesBiochemical Pharmacology, 1993
- Drug metabolizing capacity in vitro and in vivo—IIBiochemical Pharmacology, 1990
- High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liverAnalytical Biochemistry, 1987
- Studies on Constituents of Angelicae dahuricae Radix. I. On a New Furocoumarin DerivativeYAKUGAKU ZASSHI, 1980
- A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice**College of Pharmacy, University of Nebraska, Lincoln 8.Journal of the American Pharmaceutical Association (Scientific ed.), 1957